Bio


Honors & Awards

1. Cum Laude Society, National Cum Laude Society 2008
2. Harvard College Research Program Fellowship, Harvard University 2009-2011
3. 1st Place, Therapeutics Category, University Research and Entrepreneurship Symposium 2011
4. Quantitative Biosciences Consortium Fellowship, University of California San Francisco 2012
5. Honorable Mention, National Science Foundation Graduate Research Fellowship Program 2013
6. Honorable Mention, Ford Foundation Fellowship 2014
7. American Heart Association Fellowship, American Heart Association 2015
8. Best Poster, Bay Area Aging Meeting 2015
9. Hillblom Center for the Biology of Aging Fellowship, Hillblom Center for the Biology of Aging 2016
10. Travel Award Winner, ASCB, Else Kröner-Fresenius, Keystone Symposium NIA Scholarship, ISSCR, Seahorse Bioscience, UCSF 2013-2017
11. Merit Award Winner, International Society for Stem Cell Research 2017
12. Forbes 30 Under 30, Forbes 2019
13. Jane Coffin Childs Fellowship, Jane Coffin Childs Memorial Fund and Howard Hughes Medical Institute 2019
14. Invited speaker, Tedx Middlebury 2019


Professional Education

Bachelor of Arts, Harvard University (2012)
Masters of Science, Harvard University (2012)
Doctor of Philosophy, University of California San Francisco (2017)


Stanford Advisors

Karl Deisseroth, Postdoctoral Faculty Sponsor


Publications

1. Autophagy maintains the metabolism and function of young and old stem cells, Nature 2017 (PubMed ID – 28241143)
2. Aged hematopoietic stem cells are refractory to bloodborne systemic rejuvenation interventions, J Exp Med 2021 (PubMed ID – 34032859)
3. Metabolic regulation of stem cell function in tissue homeostasis and organismal ageing, Nature Cell Biology 2016 (PubMed ID – 27428307)
4. siRNA Delivery Impedes the Temporal Expression of Cytokine-Activated VCAM1 on Endothelial Cells, Annals of biomedical engineering 2016 (PubMed ID – 26101035)
5. Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesis, Elife 2015 (PubMed ID – 26193121)
6. Lysosome activation clears aggregates and enhances quiescent neural stem cell activation during aging, Science 2018 (PubMed ID – 29590078)

Academic Appointments


Honors & Awards


  • Jane Coffin Childs Fellowship, Jane Coffin Childs Memorial Fund and HHMI (2019)
  • Forbes 30 Under 30, Forbes (2019)
  • Merit Award Winner, International Society for Stem Cell Research (2017)
  • Hillblom Center for the Biology of Aging Fellowship, Hillblom Center for the Biology of Aging (2016)
  • American Heart Association Fellowship, American Heart Association (2015)
  • Travel Award Winner, ASCB, Else Kröner-Fresenius, Keystone Symposium NIA Scholarship, ISSCR, Seahorse Bioscience, UCSF (2013-2017)
  • Best Poster, Bay Area Aging Meeting (2015)
  • Honorable Mention, Ford Foundation Fellowship (2014)
  • Honorable Mention, National Science Foundation Graduate Research Fellowship Program (2013)
  • Quantitative Biosciences Consortium Fellowship, University of California San Francisco (2012)
  • 1st Place, Therapeutics Category, University Research and Entrepreneurship Symposium (2011)
  • Harvard College Research Program Fellowship, Harvard University (2009-2011)
  • Cum Laude Society, National Cum Laude Society (2008)

Boards, Advisory Committees, Professional Organizations


  • Manuscript Reviewer, Journal of Experimental Medicine, Aging Cell (2018 - Present)
  • Member, Finance & Audit Committee, American Society for Cell Biology (2014 - 2017)
  • Co-Chair, Bernfield/Gilula Awards Joint Selection Committee, American Society for Cell Biology (2013 - 2016)
  • Founder and Co-Chair, Committee for Postdocs and Students, American Society for Cell Biology (2013 - 2016)
  • President and Founder, Harvard Undergraduate Biotechnology Association (2010 - 2012)

Professional Education


  • Bachelor of Arts, Harvard University, Human Developmental and Regenerative Biology (2012)

Community and International Work


  • Committee for Postdocs and Students

    Topic

    Scientific professional development and community outreach

    Partnering Organization(s)

    American Society for Cell Biology

    Location

    International

    Ongoing Project

    No

    Opportunities for Student Involvement

    Yes

All Publications


  • Autophagy maintains the metabolism and function of young and old stem cells NATURE Ho, T. T., Warr, M. R., Adelman, E. R., Lansinger, O. M., Flach, J., Verovskaya, E. V., Figueroa, M. E., Passegue, E. 2017; 543 (7644): 205-+

    Abstract

    With age, haematopoietic stem cells lose their ability to regenerate the blood system, and promote disease development. Autophagy is associated with health and longevity, and is critical for protecting haematopoietic stem cells from metabolic stress. Here we show that loss of autophagy in haematopoietic stem cells causes accumulation of mitochondria and an activated metabolic state, which drives accelerated myeloid differentiation mainly through epigenetic deregulations, and impairs haematopoietic stem-cell self-renewal activity and regenerative potential. Strikingly, most haematopoietic stem cells in aged mice share these altered metabolic and functional features. However, approximately one-third of aged haematopoietic stem cells exhibit high autophagy levels and maintain a low metabolic state with robust long-term regeneration potential similar to healthy young haematopoietic stem cells. Our results demonstrate that autophagy actively suppresses haematopoietic stem-cell metabolism by clearing active, healthy mitochondria to maintain quiescence and stemness, and becomes increasingly necessary with age to preserve the regenerative capacity of old haematopoietic stem cells.

    View details for DOI 10.1038/nature21388

    View details for Web of Science ID 000395688700031

    View details for PubMedID 28241143

    View details for PubMedCentralID PMC5344718

  • Lysosome activation clears aggregates and enhances quiescent neural stem cell activation during aging SCIENCE Leeman, D. S., Hebestreit, K., Ruetz, T., Webb, A. E., McKay, A., Pollina, E. A., Dulken, B. W., Zhao, X., Yeo, R. W., Ho, T. T., Mahmoudi, S., Devarajan, K., Passegue, E., Rando, T. A., Frydman, J., Brunet, A. 2018; 359 (6381): 1277–82

    Abstract

    In the adult brain, the neural stem cell (NSC) pool comprises quiescent and activated populations with distinct roles. Transcriptomic analysis revealed that quiescent and activated NSCs exhibited differences in their protein homeostasis network. Whereas activated NSCs had active proteasomes, quiescent NSCs contained large lysosomes. Quiescent NSCs from young mice accumulated protein aggregates, and many of these aggregates were stored in large lysosomes. Perturbation of lysosomal activity in quiescent NSCs affected protein-aggregate accumulation and the ability of quiescent NSCs to activate. During aging, quiescent NSCs displayed defects in their lysosomes, increased accumulation of protein aggregates, and reduced ability to activate. Enhancement of the lysosome pathway in old quiescent NSCs cleared protein aggregates and ameliorated the ability of quiescent NSCs to activate, allowing them to regain a more youthful state.

    View details for PubMedID 29590078

    View details for PubMedCentralID PMC5915358

  • Metabolic regulation of stem cell function in tissue homeostasis and organismal ageing NATURE CELL BIOLOGY Chandel, N. S., Jasper, H., Ho, T. T., Passegue, E. 2016; 18 (8): 823–32

    Abstract

    Many tissues and organ systems in metazoans have the intrinsic capacity to regenerate, which is driven and maintained largely by tissue-resident somatic stem cell populations. Ageing is accompanied by a deregulation of stem cell function and a decline in regenerative capacity, often resulting in degenerative diseases. The identification of strategies to maintain stem cell function and regulation is therefore a promising avenue to allay a wide range of age-related diseases. Studies in various organisms have revealed a central role for metabolic pathways in the regulation of stem cell function. Ageing is associated with extensive metabolic changes, and interventions that influence cellular metabolism have long been recognized as robust lifespan-extending measures. In this Review, we discuss recent advances in our understanding of the metabolic control of stem cell function, and how stem cell metabolism relates to homeostasis and ageing.

    View details for DOI 10.1038/ncb3385

    View details for Web of Science ID 000380829200001

    View details for PubMedID 27428307

  • siRNA Delivery Impedes the Temporal Expression of Cytokine-Activated VCAM1 on Endothelial Cells ANNALS OF BIOMEDICAL ENGINEERING Ho, T. T., You, J., Auguste, D. T. 2016; 44 (4): 895–902

    Abstract

    Leukocyte recruitment plays a key role in chronic inflammatory diseases such as cardiovascular disease, rheumatoid arthritis, and cancer. Leukocyte rolling and arrest are mediated in part by the temporally-regulated surface expression of vascular cell adhesion molecule-1 (VCAM1) on endothelial cells (ECs). In this paper, we engineered a pH-responsive vehicle comprised of 30 mol% dimethylaminoethyl methacrylate (30D) and 70 mol% hydroxyethyl methacrylate (70H) to encapsulate, protect, and deliver VCAM1 small interfering RNA (siRNA). The ability of siRNA to reduce VCAM1 gene expression is in direct opposition to its activation by cytokines. At 12 h post-activation, VCAM1 gene knockdown was 90.1 ± 7.5% when delivered via 30D/70H nanoparticles, which was on par with a leading commercial transfection agent. This translated into a 68.8 ± 6.7% reduction in the surface density of VCAM1 on cytokine-activated ECs. The pH-responsive delivery of VCAM1 siRNA efficiently reduced temporal surface protein expression, which may be used to avert leukocyte recruitment.

    View details for DOI 10.1007/s10439-015-1364-x

    View details for Web of Science ID 000373741800006

    View details for PubMedID 26101035

  • Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesis ELIFE Wong, J. C., Weinfurtner, K. M., Alzamora, M., Kogan, S. C., Burgess, M. R., Zhang, Y., Nakitandwe, J., Ma, J., Cheng, J., Chen, S., Ho, T. T., Flach, J., Reynaud, D., Passegue, E., Downing, J. R., Shannon, K. 2015; 4

    Abstract

    Chromosome 7 deletions are highly prevalent in myelodysplastic syndrome (MDS) and likely contribute to aberrant growth through haploinsufficiency. We generated mice with a heterozygous germ line deletion of a 2-Mb interval of chromosome band 5A3 syntenic to a commonly deleted segment of human 7q22 and show that mutant hematopoietic cells exhibit cardinal features of MDS. Specifically, the long-term hematopoietic stem cell (HSC) compartment is expanded in 5A3(+/del) mice, and the distribution of myeloid progenitors is altered. 5A3(+/del) HSCs are defective for lymphoid repopulating potential and show a myeloid lineage output bias. These cell autonomous abnormalities are exacerbated by physiologic aging and upon serial transplantation. The 5A3 deletion partially rescues defective repopulation in Gata2 mutant mice. 5A3(+/del) hematopoietic cells exhibit decreased expression of oxidative phosphorylation genes, increased levels of reactive oxygen species, and perturbed oxygen consumption. These studies provide the first functional data linking 7q22 deletions to MDS pathogenesis.

    View details for DOI 10.7554/eLife.07839

    View details for Web of Science ID 000373853200001

    View details for PubMedID 26193121

    View details for PubMedCentralID PMC4569895